JESSICA JORDAN: Open Payments
NPI 1164068235 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,452 in 70 payments from 21 companies in 2025. Trend: 2023 $1,046 · 2024 $1,483 · 2025 $1,452
Food & beverage: $1,452
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $202 |
| PFIZER INC. | 9 | $153 |
| E.R. Squibb & Sons, L.L.C. | 7 | $122 |
| Merck Sharp & Dohme LLC | 5 | $110 |
| Novartis Pharmaceuticals Corporation | 6 | $109 |
| Daiichi Sankyo Inc. | 4 | $97 |
| ABBVIE INC. | 4 | $80 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $78 |
| Janssen Biotech, Inc. | 3 | $78 |
| Lilly USA, LLC | 3 | $60 |
Products named: OPDIVO, KEYTRUDA, Enhertu, LYNPARZA, RYBREVANT, CALQUENCE, KISQALI, VERZENIO.
Industry payments across AL — which companies pay providers there.
